Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death
about
Targeting p97 to Disrupt Protein Homeostasis in CancerNuclear assembly as a target for anti-cancer therapiesProteasome-mediated processing of Nrf1 is essential for coordinate induction of all proteasome subunits and p97Altered cofactor regulation with disease-associated p97/VCP mutationsTargeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasisp97-dependent retrotranslocation and proteolytic processing govern formation of active Nrf1 upon proteasome inhibitionImmune-associated proteins with potential in�vivo anti-tumor activities are upregulated in lung cancer cells treated with umbelliprenin: A proteomic approachSuramin inhibits Hsp104 ATPase and disaggregase activityDendrimer-Based Selective Proteostasis-Inhibition Strategy to Control NSCLC Growth and ProgressionBOK Is a Non-canonical BCL-2 Family Effector of Apoptosis Regulated by ER-Associated DegradationA non-canonical role of the p97 complex in RIG-I antiviral signalingUSP7 is a SUMO deubiquitinase essential for DNA replicationTumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in CancerSystematic proteomics of the VCP-UBXD adaptor network identifies a role for UBXN10 in regulating ciliogenesis.VCP/p97 cooperates with YOD1, UBXD1 and PLAA to drive clearance of ruptured lysosomes by autophagy.Cdc48 and a ubiquitin ligase drive disassembly of the CMG helicase at the end of DNA replicationQuantitative interaction mapping reveals an extended UBX domain in ASPL that disrupts functional p97 hexamers.Withaferin A Analogs That Target the AAA+ Chaperone p97.Multi-class computational evolution: development, benchmark evaluation and application to RNA-Seq biomarker discovery.A Mighty "Protein Extractor" of the Cell: Structure and Function of the p97/CDC48 ATPase.Degradation of the deubiquitinating enzyme USP33 is mediated by p97 and the ubiquitin ligase HERC2.Specific inhibition of p97/VCP ATPase and kinetic analysis demonstrate interaction between D1 and D2 ATPase domainsFunctional chromatography reveals three natural products that target the same protein with distinct mechanisms of action.Discovery of Sulfonamidebenzamides as Selective Apoptotic CHOP Pathway Activators of the Unfolded Protein Response.Evaluating p97 inhibitor analogues for their domain selectivity and potency against the p97-p47 complex.Novel VCP modulators mitigate major pathologies of rd10, a mouse model of retinitis pigmentosa.Proteotoxic crisis, the ubiquitin-proteasome system, and cancer therapy.A Fragment-Based Ligand Screen Against Part of a Large Protein Machine: The ND1 Domains of the AAA+ ATPase p97/VCP.Pharmacological targeting of valosin containing protein (VCP) induces DNA damage and selectively kills canine lymphoma cellsA ROS-Activatable Agent Elicits Homologous Recombination DNA Repair and Synergizes with Pathway CompoundsDesigning Irreversible Inhibitors--Worth the Effort?Inhibitors of the AAA+ chaperone p97Structure-Activity Study of Bioisosteric Trifluoromethyl and Pentafluorosulfanyl Indole Inhibitors of the AAA ATPase p97.The host ubiquitin-dependent segregase VCP/p97 is required for the onset of human cytomegalovirus replication.Chemical Modulation of Endocytic Sorting Augments Adeno-associated Viral Transduction.p97/VCP promotes Cullin-RING-ubiquitin-ligase/proteasome-dependent degradation of IκBα and the preceding liberation of RelA from ubiquitinated IκBα.Inadequate fine-tuning of protein synthesis and failure of amino acid homeostasis following inhibition of the ATPase VCP/p97Allosteric Indole Amide Inhibitors of p97: Identification of a Novel Probe of the Ubiquitin Pathway.The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies.Mitochondrial ClpP activity is required for cisplatin resistance in human cells.
P2860
Q26740517-876ACC98-B545-4DC1-BB5F-FE863937699FQ26852806-AEBF3064-5A8F-4FF2-B4BE-7455E9AD024FQ28243388-5B027E35-11AB-4FC5-B93E-989E8F5D200AQ28258936-A1418C1E-EBB3-4514-AA07-631029A5E096Q28269674-344BB07E-BC4B-402F-8796-6CE8F5FBFCC4Q28306282-2F5EE7B2-AEC1-414F-899C-300561B8A89CQ28468345-FE429095-3AB8-4898-A130-E7CB47807513Q28543672-7E4E5A34-B56F-4A94-B986-A0E58185D4C7Q28552714-EFEC5DB3-1486-4070-8736-D11016040D4BQ28593563-52616336-6992-4D64-B71C-802ABBCCDE4BQ28596603-281CF82B-99FF-4A05-8CB9-0D8F45F2A982Q28834083-BE5F7217-4AF9-4001-AB34-385ED3E9B4B3Q29248711-39B0A030-19A6-4FC7-B6BD-5D9E2445CDB0Q29871526-F7FBAEFC-1E88-4617-B40D-5BB557D48F42Q30274624-4C296AF2-0913-403A-B1BC-23D020000EC6Q30663146-1B677525-F8A9-4D47-9379-8B85292B0743Q30826494-5E5D5AF1-94AF-4A78-BF20-310B9098D83FQ33360763-671685B3-F186-4190-8869-E428D0054B5EQ33601127-D6F5AFFE-3408-4979-ABE5-87545208374CQ33790385-F2A3F215-BF45-4E09-B8D6-10914CEBCE04Q33888656-E914E311-AC8B-4817-A340-A93C9CF441E4Q33916854-78D1CA9B-0A0D-4B5C-B4D8-DBB061473966Q34295600-4382A6D6-0920-46C1-B9F6-014D0D0EF33AQ34701285-975D4522-DEA7-4D72-890C-B25620797084Q34791483-D06E5E34-6917-4F8B-9D3D-04A206B6BA33Q35219849-54BAC6DF-5F9F-4CC2-AC0F-738BD8DDC1B1Q35408665-A227FDDA-F636-4573-8C89-FA83C4EE005CQ35563032-D3E8B1D5-47C1-4D1C-B556-CEC0B2E638FCQ35672293-FA75C1C0-01CA-468F-AF16-1EAD17A9FC85Q35792527-5F321D8D-A864-413A-8020-75FA9264BB93Q35848315-67E4AFA0-DB96-4E7D-AB45-9F70857999FAQ36078289-CFE62BBE-39C2-4757-A07B-36EE425A41D5Q36367307-02F37C78-54B2-4EDE-BCED-5FA83BBA4221Q36369230-5B95D4E0-4D01-498C-9BDA-B896DEC95EF7Q36442455-E1670392-8F8F-451B-AF58-C540BC427C77Q36476873-28598EEC-E75F-43A8-9387-8D86437E2A99Q36485185-A05CB09C-F590-4093-94FB-6C1A396C66EAQ36579840-CF5980DD-25F0-4055-B1A0-3FC75CA634A8Q36584337-FBE8FC62-C6D2-4F17-94F7-C9C690019A02Q36677047-E8229AB2-D105-4759-AA6C-4C362F9A29AA
P2860
Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death
@ast
Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death
@en
Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death
@nl
type
label
Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death
@ast
Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death
@en
Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death
@nl
prefLabel
Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death
@ast
Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death
@en
Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death
@nl
P2093
P2860
P3181
P356
P1476
Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death
@en
P2093
Antonella Isacchi
Antonella Leone
Arturo Galvani
Barbara Valsasina
Chihunt Wong
Christian Orrenius
Claudia Perrera
Daniela Asa
Daniele Donati
Dario Ballinari
P2860
P2888
P304
P3181
P356
10.1038/NCHEMBIO.1313
P407
P577
2013-07-28T00:00:00Z